Sun Pharmaceutical (SUNPHARMA) — Financial Results

Sun Pharmaceutical announced its Q2 FY2026 earnings call scheduled for 05 November 2025 at 06:30 pm IST, where senior management will discuss company performance and field investor questions. Results will be released on the same date via www.sunpharma.com. The one-hour conference call will be accessible via phone lines and audio webcast, with transcripts available post-call. This is a routine earnings announcement for the quarter ended 30 September 2025.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this financial results affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 15 October 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 15 October 2025

SBICARD SBI Cards and Payment Services Limited Financial Results AXISBANK Axis Bank Limited Financial Results WIPRO Wipro Limited Corporate Action AMBUJACEM Ambuja Cements Limited Financial Results TECHM Tech Mahindra Limited Financial Results AXISBANK Axis Bank Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.